Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

  1. Khushalani, N.I.
  2. Ott, P.A.
  3. Ferris, R.L.
  4. Cascone, T.
  5. Schadendorf, D.
  6. Le, D.T.
  7. Sharma, M.R.
  8. Barlesi, F.
  9. Sharfman, W.
  10. Luke, J.J.
  11. Melero, I.
  12. Lathers, D.
  13. Neely, J.
  14. Suryawanshi, S.
  15. Sanyal, A.
  16. Holloway, J.L.
  17. Suryawanshi, R.
  18. Ely, S.
  19. Segal, N.H.
Revista:
Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426

Any de publicació: 2024

Volum: 12

Número: 3

Tipus: Article

DOI: 10.1136/JITC-2023-007364 GOOGLE SCHOLAR lock_openAccés obert editor

Objectius de Desenvolupament Sostenible

Font de les dades: Scopus